BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35396711)

  • 21. Biology, clinical course and management of nodular lymphocyte-predominant hodgkin lymphoma.
    Nogová L; Rudiger T; Engert A
    Hematology Am Soc Hematol Educ Program; 2006; ():266-72. PubMed ID: 17124071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence, clinicopathological features and outcome of primary central nervous system lymphomas. Population-based data from a Danish lymphoma registry. Danish Lymphoma Study Group, LYFO.
    Krogh-Jensen M; d'Amore F; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
    Ann Oncol; 1994 Apr; 5(4):349-54. PubMed ID: 8075032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of routine imaging in detecting recurrent lymphoma: A review of 258 patients with relapsed aggressive non-Hodgkin and Hodgkin lymphoma.
    El-Galaly TC; Mylam KJ; Bøgsted M; Brown P; Rossing M; Gang AO; Haglund A; Arboe B; Clausen MR; Jensen P; Pedersen M; Bukh A; Jensen BA; Poulsen CB; d'Amore F; Hutchings M
    Am J Hematol; 2014 Jun; 89(6):575-80. PubMed ID: 24493389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of Epstein-Barr virus in Hodgkin lymphoma in a population of United Arab Emirates nationals.
    Al-Salam S; John A; Daoud S; Chong SM; Castella A
    Leuk Lymphoma; 2008 Sep; 49(9):1769-77. PubMed ID: 18661399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hodgkin lymphoma: 2016 update on diagnosis, risk-stratification, and management.
    Ansell SM
    Am J Hematol; 2016 Jun; 91(4):434-42. PubMed ID: 27001163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advanced-stage nodular lymphocyte predominant Hodgkin lymphoma compared with classical Hodgkin lymphoma: a matched pair outcome analysis.
    Xing KH; Connors JM; Lai A; Al-Mansour M; Sehn LH; Villa D; Klasa R; Shenkier T; Gascoyne RD; Skinnider B; Savage KJ
    Blood; 2014 Jun; 123(23):3567-73. PubMed ID: 24713929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential expression patterns of c-REL protein in classic and nodular lymphocyte predominant Hodgkin lymphoma.
    Xiao Q; Shen N; Hedvat CV; Moskowitz CH; Sussman LK; Filippa DA; Zelenetz AD; Houldsworth J; Chaganti RS; Teruya-Feldstein J
    Appl Immunohistochem Mol Morphol; 2004 Sep; 12(3):211-5. PubMed ID: 15551733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathological features, survival and prognostic factors of primary central nervous system lymphomas: trends in incidence of primary central nervous system lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the Danish Lymphoma Registry, LYFO, and the Danish Cancer Registry.
    Krogh-Jensen M; D'Amore F; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
    Leuk Lymphoma; 1995 Oct; 19(3-4):223-33. PubMed ID: 8535213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GATA3 Immunohistochemical Staining in Hodgkin Lymphoma: Diagnostic Utility in Differentiating Classic Hodgkin Lymphoma From Nodular Lymphocyte Predominant Hodgkin Lymphoma and Other Mimicking Entities.
    Kezlarian B; Alhyari M; Venkataraman G; Karner K; Inamdar KV; Menon MP
    Appl Immunohistochem Mol Morphol; 2019 Mar; 27(3):180-184. PubMed ID: 28877074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nodular lymphocyte predominant Hodgkin lymphoma.
    Lee AI; LaCasce AS
    Oncologist; 2009 Jul; 14(7):739-51. PubMed ID: 19605845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Real-World Outcomes of Hodgkin Lymphoma: A Multi-Centric Registry From India.
    Bhurani D; Nair R; Rajappa S; Rao SA; Sridharan N; Boya RR; Raman GS; Menon H; Seshachalam A; Nimmagadda R
    Front Oncol; 2021; 11():799948. PubMed ID: 35223455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A 20-year population-based study on the epidemiology, clinical features, treatment, and outcome of nodular lymphocyte predominant Hodgkin lymphoma.
    Strobbe L; Valke LL; Diets IJ; van den Brand M; Aben K; Raemaekers JM; Hebeda KM; van Krieken JH
    Ann Hematol; 2016 Feb; 95(3):417-23. PubMed ID: 26732883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990-2012).
    Baras N; Dahm S; Haberland J; Janz M; Emrich K; Kraywinkel K; Salama A
    Br J Haematol; 2017 Apr; 177(2):226-242. PubMed ID: 28106907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The time to relapse correlates with the histopathological growth pattern in nodular lymphocyte predominant Hodgkin lymphoma.
    Hartmann S; Plütschow A; Mottok A; Bernd HW; Feller AC; Ott G; Cogliatti S; Fend F; Quintanilla-Martinez L; Stein H; Klapper W; Möller P; Rosenwald A; Engert A; Hansmann ML; Eichenauer DA
    Am J Hematol; 2019 Nov; 94(11):1208-1213. PubMed ID: 31396979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Nodular lymphocyte-predominant Hodgkin's lymphoma: Principles of diagnosis and treatment].
    Moiseeva TN; Al-Radi LS; Kovrigina AM; Goryacheva SR; Julakyan UL; Margolin OV; Skidan NI; Tseytlina MA; Kravchenko SK
    Ter Arkh; 2015; 87(11):78-83. PubMed ID: 26821421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hodgkin lymphoma: A 2020 update on diagnosis, risk-stratification, and management.
    Ansell SM
    Am J Hematol; 2020 Aug; 95(8):978-989. PubMed ID: 32384177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hodgkin lymphoma--a survey of children and adolescents treated in Sweden 1985-2009.
    Englund A; Hopstadius C; Enblad G; Gustafsson G; Ljungman G
    Acta Oncol; 2015 Jan; 54(1):41-8. PubMed ID: 25203597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single-cell profiling reveals the importance of CXCL13/CXCR5 axis biology in lymphocyte-rich classic Hodgkin lymphoma.
    Aoki T; Chong LC; Takata K; Milne K; Marshall A; Chavez EA; Miyata-Takata T; Ben-Neriah S; Unrau D; Telenius A; Boyle M; Weng AP; Savage KJ; Scott DW; Farinha P; Shah SP; Nelson BH; Steidl C
    Proc Natl Acad Sci U S A; 2021 Oct; 118(41):. PubMed ID: 34615710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival of Patients With Second Primary Hodgkin Lymphoma.
    Budnik J; Doucette C; Milano MT; Constine LS
    Clin Lymphoma Myeloma Leuk; 2020 May; 20(5):316-323.e2. PubMed ID: 32014390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hodgkin lymphoma: 2014 update on diagnosis, risk-stratification, and management.
    Ansell SM
    Am J Hematol; 2014 Jul; 89(7):771-9. PubMed ID: 24953862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.